TH151328A - Recombinant RSV antigen - Google Patents
Recombinant RSV antigenInfo
- Publication number
- TH151328A TH151328A TH1101003808A TH1101003808A TH151328A TH 151328 A TH151328 A TH 151328A TH 1101003808 A TH1101003808 A TH 1101003808A TH 1101003808 A TH1101003808 A TH 1101003808A TH 151328 A TH151328 A TH 151328A
- Authority
- TH
- Thailand
- Prior art keywords
- rsv
- recombinant
- prevention
- antigen
- preparation
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title claims abstract 7
- 102000038129 antigens Human genes 0.000 title claims abstract 7
- 108091007172 antigens Proteins 0.000 title claims abstract 7
- 241000724205 Rice stripe tenuivirus Species 0.000 title 1
- 230000002265 prevention Effects 0.000 claims abstract 4
- 229960005486 vaccines Drugs 0.000 claims abstract 4
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 claims abstract 3
- 230000000241 respiratory Effects 0.000 claims abstract 3
- 241000700605 Viruses Species 0.000 claims abstract 2
- 239000000470 constituent Substances 0.000 claims abstract 2
- 108060003023 F Proteins 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 230000003899 glycosylation Effects 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000006011 modification reaction Methods 0.000 claims 1
- 229960003444 IMMUNOSUPPRESSANTS Drugs 0.000 abstract 1
- 230000001861 immunosuppresant Effects 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 230000035812 respiration Effects 0.000 abstract 1
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract 1
Abstract
DC60 (24/01/55) การเปิดเผยนี้จัดเตรียมแอนติเจนไวรัสซินไซเทียลรีคอมบิแนนท์ของการหายใจ (RSV) และวิธีการสำหรับการเตรียมและการใช้สิ่งเหล่านี้, รวมทั้งองค์ประกอบที่สร้างภูมิคุ้มกัน (เช่น, วัคซีน) สำหรับการรักษาและ/หรือการป้องกันการติดเชื้อ RSV การเปิดเผยนี้จัดเตรียมแอนติเจนไวรัสซินไซเทียลรีคอมบิแนนท์ของการหายใจ(RSV) และวิธีการสำหรับการเตรียมและการใช่สิ่งเหล่านี้,รวมทั้งองค์ประกอบที่สร้างภูมิคุ้มกัน (เช่น,วัคซีน) สำหรับการรักษาและ/หรือการป้องกันการติดเชื้อ RSV สิทธิบัตรยา DC60 (24/01/55) This disclosure provides respiration syncretine virus recombinant (RSV) antigens and methods for their preparation and use, as well as the constituents that generate Immunosuppressants (eg, vaccines) for the treatment and / or prevention of RSV infection. This disclosure provides the respiratory recombinant (RSV) antigen (RSV) and means for preparation and administration. Yes, these, including immune-building components (Eg, vaccines) for the treatment and / or prevention of RSV infection.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH151328A true TH151328A (en) | 2016-05-19 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1117673T1 (en) | Recombinant RSV antigens | |
| EA201070794A1 (en) | Recombinant antigens RSV | |
| MY169352A (en) | Vaccine against rsv | |
| GEP20217260B (en) | Antibody neutralizing human respiratory syncytial virus | |
| WO2006115843A3 (en) | Nipah virus vaccines | |
| WO2014160463A8 (en) | Prefusion rsv f proteins and their use | |
| WO2012024632A3 (en) | Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e | |
| MX2019003682A (en) | Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same. | |
| EP4272750A3 (en) | Protein antigens that provide protection against pneumococcal colonization and/or disease | |
| WO2017040387A3 (en) | Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine | |
| ES2555557R1 (en) | Drug and use to prepare a drug for the prevention of HIV infection and the treatment of HIV-caused diseases, including AIDS | |
| WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
| DK3016673T3 (en) | Mammalian milk osteopontin to improve immune response | |
| AR065765A1 (en) | VACCINE COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIOUS DISEASES | |
| WO2014074817A3 (en) | Attenuated mannheimia haemolytica vaccines and methods of making and use | |
| WO2010080188A3 (en) | Epitope targeted anthrax vaccine | |
| TH151328A (en) | Recombinant RSV antigen | |
| WO2013173256A3 (en) | New and improved influenza vaccines | |
| TH168425A (en) | Elements for the prevention and treatment of mycoplasma infection. | |
| WO2009117365A3 (en) | Vaccine compositions for inducing immune responses against components of drusen | |
| PH12014502013A1 (en) | Vaccine against rsv | |
| TH175548A (en) | Hand, foot and mouth disease vaccines and methods for their production and use. | |
| TH158445A (en) | Recombinant Coyherpes Virus (KHV) and Vaccine for the prevention of disease induced by KHV. | |
| TH156774A (en) | Human monoclonal antibodies With specificity for denguexirite 1 E virus proteins and their use (HUMAN MONOCLONAL ANTIBODY WITH SPECIFICITY FOR DENGUE VIRUS SEROTYPE 1 E PROTEIN AND USES THEREOF). | |
| TH160505A (en) | Compounds and methods for enhancing the innate immune response |